Related Experiment Video
Updated: Jun 8, 2026
06:58
An Application for Pairing with Wearable Devices to Monitor Personal Health Status
Published on: February 3, 2022
Evolution of a web-based, prototype Personal Health Application for diabetes self-management
Stephanie J Fonda1, Richard J Kedziora2, Robert A Vigersky1
1Endocrinology Service, Department of Medicine, Walter Reed Army Medical Center, Washington, DC, USA.
Journal of Biomedical Informatics
|October 13, 2010
Summary
This study introduces a prototype Personal Health Application (PHA) designed to aid diabetes self-management. The PHA analyzes personal health data, providing feedback to support individuals in managing their condition effectively.
Area of Science:
- Digital Health
- Diabetes Management
- Health Informatics
Background:
- Self-management behaviors are critical for individuals with diabetes.
- Existing tools may not fully support comprehensive diabetes self-management.
- User-Centered Design (UCD) principles can guide the development of effective health applications.
Purpose of the Study:
- To present the prototype Personal Health Application (PHA) for diabetes self-management.
- To describe modifications made to the PHA based on user feedback and testing.
- To align the PHA with the vision of Project Health Design (PHD).
Main Methods:
- Developed a prototype Personal Health Application (PHA) using User-Centered Design principles.
- Integrated the PHA with a Personal Health Record (PHR) to receive diabetes management data.
- Analyzed data and provided feedback using clinically vetted educational content via a website portal.
- Incorporated user feedback and timing tests to refine the PHA's functionality.
Main Results:
- The prototype PHA successfully received and processed diabetes management data from a PHR.
- Modifications included re-conceptualizing information display ('gadgets') and focusing on low-cost data entry.
- The PHA was synchronized with a new PHR, Microsoft® HealthVault™.
Conclusions:
- The Personal Health Application (PHA) shows promise in supporting diabetes self-management.
- Iterative development based on user feedback and technological advancements is crucial for health application improvement.
- Future iterations aim to enhance accessibility and user engagement in diabetes care.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...